175 related articles for article (PubMed ID: 35011628)
1. The Isoquinoline-Sulfonamide Compound H-1337 Attenuates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Rats.
Shoji H; Yoshida Y; Sanada TJ; Naito A; Maruyama J; Zhang E; Sumi K; Sakao S; Maruyama K; Hidaka H; Tatsumi K
Cells; 2021 Dec; 11(1):. PubMed ID: 35011628
[TBL] [Abstract][Full Text] [Related]
2. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
6. Dacomitinib, a new pan-EGFR inhibitor, is effective in attenuating pulmonary vascular remodeling and pulmonary hypertension.
Yu X; Zhao X; Zhang J; Li Y; Sheng P; Ma C; Zhang L; Hao X; Zheng X; Xing Y; Qiao H; Qu L; Zhu D
Eur J Pharmacol; 2019 May; 850():97-108. PubMed ID: 30753867
[TBL] [Abstract][Full Text] [Related]
7. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
[TBL] [Abstract][Full Text] [Related]
8. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.
Tang H; Chen J; Fraidenburg DR; Song S; Sysol JR; Drennan AR; Offermanns S; Ye RD; Bonini MG; Minshall RD; Garcia JG; Machado RF; Makino A; Yuan JX
Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L208-20. PubMed ID: 25416384
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433
[TBL] [Abstract][Full Text] [Related]
13. Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.
Ciuclan L; Sheppard K; Dong L; Sutton D; Duggan N; Hussey M; Simmons J; Morrell NW; Jarai G; Edwards M; Dubois G; Thomas M; Van Heeke G; England K
Am J Pathol; 2013 Nov; 183(5):1461-73. PubMed ID: 24160323
[TBL] [Abstract][Full Text] [Related]
14. Rivaroxaban Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Hypertension.
Imano H; Kato R; Nomura A; Tamura M; Yamaguchi Y; Ijiri Y; Wu H; Nakano T; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M; Hayashi T
Biol Pharm Bull; 2021 May; 44(5):669-677. PubMed ID: 33612567
[TBL] [Abstract][Full Text] [Related]
15. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
Chen M; Shen H; Zhu L; Yang H; Ye P; Liu P; Gu Y; Chen S
J Cell Physiol; 2019 Aug; 234(10):17482-17493. PubMed ID: 30786011
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
[TBL] [Abstract][Full Text] [Related]
17. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
[No Abstract] [Full Text] [Related]
18. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
[No Abstract] [Full Text] [Related]
19. Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells.
Liu P; Huang W; Ding Y; Wu J; Liang Z; Huang Z; Xie W; Kong H
Drug Des Devel Ther; 2021; 15():1653-1666. PubMed ID: 33935492
[TBL] [Abstract][Full Text] [Related]
20. Metformin Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Activation of Adenosine Monophosphate-Activated Protein Kinase.
Liu Y; Xu Y; Zhu J; Li H; Zhang J; Yang G; Sun Z
J Vasc Res; 2019; 56(3):117-128. PubMed ID: 31085922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
